Identification of early and intermediate biomarkers for ARDS mortality by multi-omic approaches

Abstract excerpt

The lack of successful clinical trials in acute respiratory distress syndrome (ARDS) has highlighted the unmet need for biomarkers predicting ARDS mortality and for novel therapeutics to reduce ARDS mortality. We utilized a systems biology multi-"omics" approach to identify predictive biomarkers for ARDS mortality. Integrating analyses were designed to differentiate ARDS non-survivors and survivors (568 subjects,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Eicosanoids and Hypertension Pharmacology
• Share to Respiratory Support and Mechanisms
• Share to Sepsis Diagnosis and Treatment